iwCLL 2017 program: the biology of CLL, treatment options and the relapsed/refractory setting
What are the practical considerations for monoclonal antibody infusion?
What are the challenges of allogeneic stem cell transplant in myeloma?
Is FISH becoming obsolete in multiple myeloma?
A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian